Psychopathological dimensions and addictive behaviours in Heroin Use Disorder patients

被引:0
|
作者
Maremmani, Angelo G. I. [1 ,2 ,3 ]
Rovai, Luca [1 ]
Bacciardi, Silvia [1 ]
Massimetti, Enrico [1 ]
Gazzarrini, Denise [1 ]
Pallucchini, Alessandro [1 ]
Rugani, Fabio [4 ]
Pani, Pier Paolo [5 ]
Maremmani, Icro [1 ,2 ,3 ]
机构
[1] Univ Pisa, Santa Chiara Univ Hosp, Dept Neurosci, Vincent P Dole Dual Diag Unit, I-56100 Pisa, Italy
[2] Assoc Applicat Neurosci Knowledge Social Aims AU, Via 20 Settembre 83, I-55045 Pietrasanta, Lucca, Italy
[3] G De Lisio Inst Behav Sci, Pisa, Italy
[4] Univ Naples 2, Dept Psychiat, Naples, Italy
[5] Sardinia Reg Hlth Syst, Social & Hlth Serv, Cagliari, Italy
关键词
Heroin Use Disorder; psychopathological dimensions; addictive behaviours; SYMPTOMS; INVENTORY;
D O I
暂无
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background. Specific psychopathology of Heroin Use Disorder (HUD) patients has been proved to be independent of treatment location (outpatient facilities or therapeutic communities), detoxification status, and patients' lifetime psychiatric issues. It was able to successfully discriminate between depressed patients and HUD patients. It also influenced treatment outcomes during methadone and buprenorphine treatment. When the 13 addictive behaviours of HUD patients were examined, Dual Disorder (DD) HUD patients showed a particular addictive behaviour pattern correlated with finding and taking opioids to alleviate psychopathology. In this study we tried to typify these addictive behaviours according to the severity of HUD-specific psychopathology, by checking the influence of the severity of psychopathological dimensions on the addictive behaviours we had previously found in DD-HUD patients. Methods. We examined, in this naturalistic, observational, cross-sectional study, the correlations between psychopathological dimensions and addictive behaviours in 114 HUD patients, at Agonist Opioid Treatment entry. We used the nonlinear canonical correlation analysis. Results. Significant correlations were found between severity of 'worthlessness-being trapped' and 'panic-anxiety' symptomatology, and the tendency of patients to adopt risk behaviours, using syringes that don't look good or injecting everything they think 'will work' in absence of heroin, and prizing heroin much more than anything else they ever enjoyed before. The severity of sensitivity-psychoticism symptomatology correlated with having trouble using anti-withdrawal pills and with being willing to put up with a lot of stress to get heroin. Behaviours related to obsessive craving, relief craving or cue-induced behaviours showed lower correlation with the severity of psychopathology. Conclusions. Typifying addictive behaviours in HUD patients on the basis of the severity of their psychopathological dimensions is possible only for depressed-anxious or sensitive-psychotic patients, who are characterized by risk behaviours and with finding and taking opioids to alleviate psychopathology. The majority of addictive behaviours we investigated were not related to the severity of the psychopathology shown.
引用
收藏
页码:43 / 50
页数:8
相关论文
共 50 条
  • [1] Further evidence of a psychopathology specific to Heroin Use Disorder. Relationships between psychopathological dimensions and addictive behaviours
    Della Rocca, Filippo
    Maremmani, Angelo Giovanni Icro
    Rovai, Luca
    Bacciardi, Silvia
    Lamanna, Francesco
    Maremmani, Icro
    HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2017, 19 (06) : 13 - 19
  • [2] Further Evidence of a Psychopathology Specific to Heroin Use Disorder. Relationships between Psychopathological Dimensions and Addictive Behaviours
    Della Rocca, F.
    Maremmani, A. G. I.
    Rovai, L.
    Bacciardi, S.
    Lamanna, F.
    Maremmani, I.
    HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2018, 20 : 62 - 63
  • [3] Addictive behaviours in Heroin Use Disorder patients. Correlation with heroin-craving patients' self-evaluation
    Maremmani, Angelo Giovanni Icro
    Rovai, Luca
    Bacciardi, Silvia
    Bertoni, Sara
    Massimetti, Enrico
    Gazzarrini, Denise
    Rugani, Fabio
    Pallucchini, Alessandro
    Maremmani, Icro
    HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2016, 18 (01) : 9 - 17
  • [4] Relationships between addictive behaviours and dual disorders, as found in heroin use disorder patients at treatment entry
    Maremmani, Angelo G. I.
    Rovai, Luca
    Bacciardi, Silvia
    Massimetti, Enrico
    Gazzarrini, Denise
    Pallucchini, Alessandro
    Pani, Pier Paolo
    Maremmani, Icro
    HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2016, 18 (02) : 5 - 12
  • [5] Addictive behaviours of heroin addicts and specific psychopathology
    Maremmani, A. G. I.
    HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2016, 18 (03) : 33 - 33
  • [6] Psychopathological syndromes and risk of alcoholism in Heroin Use Disorder patients compared with non-substance-use peers
    Miccoli, Mario
    Della Rocca, Filippo
    Maremmani, Angelo G., I
    Maremmani, Icro
    HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2021, 23 (01) : 71 - 78
  • [7] Eating disorder risk and psychopathological dimensions
    Garrido Riquenes, Vilma
    Sala Roca, Josefina
    ANUARIO DE PSICOLOGIA, 2015, 45 (01): : 87 - 99
  • [8] Addictive behaviours: Cocaine and cannabis use
    Raposo, M. R.
    Ivanov, V.
    Martinez, I.
    Murcia, J. B.
    Gonzalez, A. L.
    Piqueras, M. D.
    Manzur, P.
    Gil, A.
    Belmar, A.
    Bravo, S.
    Bello, I.
    Rodriguez, A.
    EUROPEAN PSYCHIATRY, 2016, 33 : S314 - S314
  • [9] Addictive internet use as a comorbid disorder among clients of an adolescent psychiatry - prevalence and psychopathological symptoms
    Mueller, Kai W.
    Ammerschlaeger, Marcella
    Freisleder, Franz Joseph
    Beutel, Manfred E.
    Woelfling, Klaus
    ZEITSCHRIFT FUR KINDER-UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE, 2012, 40 (05): : 331 - 339
  • [10] Macrocytosis among patients with heroin use disorder
    Ng, Mei-Hing
    Chen, Vincent Chin-Hung
    Ting, Hua
    Lin, Tsang-Yaw
    Chang, Sheng-Huang
    Gossop, Michael
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2019, 15 : 2293 - 2298